Literature DB >> 2935673

Myocardial hypertrophy in rats with renal insufficiency.

M Rambausek, E Ritz, G Mall, O Mehls, H Katus.   

Abstract

Increased defatted dry wt of the heart and increased heart calcium content were observed in subtotally nephrectomized male Sprague-Dawley rats compared with sham-operated pairfed controls. Increased heart wt contrasted with no change of the weight of viscera (liver, spleen) and markedly decreased weight of striated muscle. Heart wt was unchanged after 5 days of renal insufficiency, but significantly increased after 14 or 21 days. Increased heart wt persisted despite effective beta adrenoreceptor blockade (2 X 10 mg metroprolol/kg/day i.p.) or effective alpha-1-adrenoreceptor blockade (2 X 2 mg prazosin/kg/day i.p.). Increased heart wt was also demonstrable despite normalization of basal blood pressure (intraarterial blood pressure measurement in conscious animals): blood pressure was lowered in one series with hydralazine/nadolol in drinking water (calculated to deliver 20 and 2 mg/kg/day, respectively) and in another series with furosemide in drinking water (15 mg/kg/day) combined with metoprolol (2 X 10 mg/kg/day i.p.). Increased heart wt was also noted despite correction of anemia by blood transfusion (Hct greater than 40%) and after parathyroidectomy in animals kept eucalcemic with high dietary calcium. Micromorphometry of left ventricular myocardium in perfusion-fixed tissue showed no significant change of the relative proportion of connective tissue and myocardial fibers. Myocardial isomyosin pattern was changed with an increase of fast-migrating V1 isomyosin in animals with renal insufficiency compared to sham-operated pairfed controls.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2935673     DOI: 10.1038/ki.1985.197

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  19 in total

1.  IκB Kinase Inhibitor Attenuates Sepsis-Induced Cardiac Dysfunction in CKD.

Authors:  Jianmin Chen; Julius E Kieswich; Fausto Chiazza; Amie J Moyes; Thomas Gobbetti; Gareth S D Purvis; Daniela C F Salvatori; Nimesh S A Patel; Mauro Perretti; Adrian J Hobbs; Massimo Collino; Muhammad M Yaqoob; Christoph Thiemermann
Journal:  J Am Soc Nephrol       Date:  2016-05-06       Impact factor: 10.121

2.  Nonhypotensive dose of beta-adrenergic blocker ameliorates capillary deficits in the hearts of rats with moderate renal failure.

Authors:  Kerstin Amann; Jürgen Hofstetter; Valentina Câmpean; Andreas Koch; Marie-Luise Gross; Roland Veelken; Eberhard Ritz
Journal:  Virchows Arch       Date:  2006-05-12       Impact factor: 4.064

Review 3.  Cardiac actions of fibroblast growth factor 23.

Authors:  Christian Faul
Journal:  Bone       Date:  2016-10-07       Impact factor: 4.398

4.  Correlative factors of left ventricular hypertrophy in end-stage renal disease.

Authors:  Y Dai; S J He; Y Yu; L Y Zhu; B Peng; J B Liu; S C Tang
Journal:  J Tongji Med Univ       Date:  1993

5.  Impairment of cardiac function and energetics in experimental renal failure.

Authors:  A E Raine; A M Seymour; A F Roberts; G K Radda; J G Ledingham
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

6.  Uremia in the rat affects gastric cell growth and differentiation.

Authors:  E Quintero; G Ohning; P H Guth
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

7.  [Kidney insufficiency and cardiovascular disease].

Authors:  B Weidtmann; H Schunkert
Journal:  Internist (Berl)       Date:  2007-08       Impact factor: 0.743

8.  Uremic cardiac hypertrophy is reversed by rapamycin but not by lowering of blood pressure.

Authors:  Andrew M Siedlecki; Xiaohua Jin; Anthony J Muslin
Journal:  Kidney Int       Date:  2009-01-21       Impact factor: 10.612

9.  High-dose enalapril treatment reverses myocardial fibrosis in experimental uremic cardiomyopathy.

Authors:  Karin Tyralla; Marcin Adamczak; Kerstin Benz; Valentina Campean; Marie-Luise Gross; Karl F Hilgers; Eberhard Ritz; Kerstin Amann
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

10.  Experimental models of renal disease and the cardiovascular system.

Authors:  Rebecca C Grossman
Journal:  Open Cardiovasc Med J       Date:  2010-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.